We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DECK icon
151
Deckers Outdoor
DECK
$13.3B
$2.03M 0.05%
10,000
-2,000
-17% -$362K
LCID icon
152
PUT
Lucid Motors
LCID
$2.75B
$2M 0.05%
157,500
LEGT
153
DELISTED
Legato Merger Corp III
LEGT
$1.99M 0.05%
+193,740
New +$1.99M
KNSA icon
154
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.97M 0.05%
99,632
+24,463
+33% +$558K
SN icon
155
SharkNinja
SN
$25.3B
$1.95M 0.05%
+20,000
New +$2.04M
INVZ icon
156
Innoviz Technologies
INVZ
$118M
$1.93M 0.05%
+1,150,000
New +$950K
IDYA icon
157
IDEAYA Biosciences
IDYA
$3.49B
$1.87M 0.05%
72,716
+24,112
+50% +$683K
INSM icon
158
Insmed
INSM
$28.9B
$1.84M 0.05%
26,615
+4,796
+22% +$345K
VISN
159
Vistance Networks Inc
VISN
$2.33B
$1.82M 0.05%
+350,000
New +$1.96M
ATEC icon
160
Alphatec Holdings
ATEC
$1.42B
$1.82M 0.05%
197,992
+35,695
+22% +$285K
KDK
161
Kodiak AI
KDK
$842M
$1.82M 0.05%
165,422
TJX icon
162
TJX Companies
TJX
$179B
$1.81M 0.05%
+15,000
New +$1.79M
BMRN icon
163
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.76M 0.04%
+26,840
New +$1.8M
BPMC
164
DELISTED
Blueprint Medicines
BPMC
$1.76M 0.04%
20,133
-2,120
-10% -$194K
ON icon
165
ON Semiconductor
ON
$18.6B
$1.73M 0.04%
27,500
+17,500
+175% +$1.21M
IRTC icon
166
iRhythm Holdings
IRTC
$4.21B
$1.73M 0.04%
19,191
-5,535
-22% -$435K
AAL icon
167
PUT
American Airlines Group
AAL
$10.6B
$1.7M 0.04%
10,645,000
+870,000
+9% +$12.5M
OFIX icon
168
Orthofix Medical
OFIX
$432M
$1.7M 0.04%
97,461
+12,578
+15% +$219K
ADI icon
169
Analog Devices
ADI
$184B
$1.7M 0.04%
8,000
+3,000
+60% +$663K
EVLV icon
170
Evolv Technologies
EVLV
$1.07B
$1.7M 0.04%
430,223
ITCI
171
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.69M 0.04%
20,284
+2,941
+17% +$242K
BBIO icon
172
BridgeBio Pharma
BBIO
$16.2B
$1.68M 0.04%
61,118
+2,522
+4% +$65.2K
CDLX icon
173
Cardlytics
CDLX
$20.7M
$1.67M 0.04%
45,000
VALE icon
174
Vale
VALE
$62.6B
$1.66M 0.04%
+187,296
New +$1.91M
ANNX icon
175
Annexon
ANNX
$918M
$1.64M 0.04%
318,884
-1,690
-0.5% -$10.4K

Similar funds

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.